EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PT Kimia Farma Tbk's Enterprise Value is Rp10,014,149 Mil.
PT Kimia Farma Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was Rp357,232 Mil. Therefore, PT Kimia Farma Tbk's EV-to-FCF for today is 28.03.
The historical rank and industry rank for PT Kimia Farma Tbk's EV-to-FCF or its related term are showing as below:
ISX:KAEF'
s EV-to-FCF Range Over the Past 10 Years
Min: -445.34 Med: -18.17 Max: 205.23
Current: 27.69
During the past 13 years, the highest EV-to-FCF of PT Kimia Farma Tbk was 205.23. The lowest was -445.34. And the median was -18.17.
ISX:KAEF's EV-to-FCF is ranked worse than 66.22% of 74
companies
in the Medical Distribution industry
Industry Median: 17.125
vs ISX:KAEF: 27.69
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Kimia Farma Tbk (ISX:KAEF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Kimia Farma Tbk's PE Ratio (TTM) for today is calculated as:
PT Kimia Farma Tbk's share price for today is Rp468.00.
PT Kimia Farma Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-28.444.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PT Kimia Farma Tbk EV-to-FCF Related Terms
PT Kimia Farma Tbk EV-to-FCF Historical Data
* Premium members only.
The historical data trend for PT Kimia Farma Tbk's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Kimia Farma Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kimia Farma Tbk EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PT Kimia Farma Tbk's EV-to-FCF falls into.
PT Kimia Farma Tbk's current Enterprise Value is Rp10,014,149 Mil.
PT Kimia Farma Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp357,232 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Tbk (ISX:KAEF) has a EV-to-FCF of 28.03 as of Jul. 09, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Kimia Farma Tbk and its competitors. According to the industry distribution chart, PT Kimia Farma Tbk ranks #49 out of 74 companies in the Medical Distribution industry, placing it in the top 66.2%.
Is PT Kimia Farma Tbk's EV-to-FCF too high?
PT Kimia Farma Tbk's current EV-to-FCF is 28.03. The Medical Distribution industry median EV-to-FCF is 17.13. PT Kimia Farma Tbk's value of 28.03 is 63.7% above this industry median. Based on the distribution chart, PT Kimia Farma Tbk ranks #49 out of 74 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, PT Kimia Farma Tbk has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Tbk's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, PT Kimia Farma Tbk ranks #49 out of 74 companies for EV-to-FCF. This places PT Kimia Farma Tbk in the lower half of its industry. The industry median EV-to-FCF is 17.13. PT Kimia Farma Tbk's value of 28.03 is 63.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.13, based on 74 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Kimia Farma Tbk's current EV-to-FCF of 28.03 is 63.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Kimia Farma Tbk and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Kimia Farma Tbk's current EV-to-FCF is 28.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp581.60, compared to a current price of Rp468.00 — trading 19.5% below its estimated fair value. The current EV-to-FCF is 28.03 and 63.7% above the Medical Distribution industry median of 17.13. PT Kimia Farma Tbk's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PT Kimia Farma Tbk (ISX:KAEF), the current EV-to-FCF is 28.03 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued.
The current stock price of Rp468.00 is trading 19.5% below its estimated GF Value™ of Rp581.60.
GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.
Key valuation signals for ISX:KAEF:
EV-to-FCF: 28.03
GF Value™: Rp581.60 vs. price of Rp468.00 (19.5% below fair value)
Industry Position: 63.7% above the Medical Distribution median (#49 of 74)
No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
51GF Score
Get the complete analysis for ISX:KAEF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:KAEF has been successfully added to your 
